SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-041137
Filing Date
2015-05-11
Accepted
2015-05-11 16:30:39
Documents
2
Period of Report
2015-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7093
2 EX-24 DOCUMENT attachment1.htm EX-24 4259
  Complete submission text file 0001209191-15-041137.txt   13231
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958
Business Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958 33 6 33554531
LFB Biotechnologies S.A.S.U. (Reporting) CIK: 0001377942 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 15851162